Baudax Bio, Inc.

CIK 1780097 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Baudax Bio, Inc..

Recent SEC filings

FiledFormAccession number
Feb 28, 20248-K0001193125-24-049000
Feb 15, 202425-NSE0001354457-24-000078
Feb 14, 2024SC 13G/A0001013594-24-000171
Feb 6, 2024SC 13G/A0001213900-24-010366
Dec 13, 20238-K0001193125-23-293726
Nov 22, 2023424B30001193125-23-282310
Nov 20, 202310-Q0000950170-23-065200
Nov 15, 2023NT 10-Q0001193125-23-278003
Nov 15, 20238-K0001193125-23-277889
Oct 25, 20238-K0001193125-23-262285
Oct 13, 20238-K0001193125-23-255644
Oct 11, 202330001062993-23-019244
Oct 10, 2023DEFA14A0001193125-23-253047
Oct 6, 20238-K0001193125-23-251966
Sep 29, 20238-K0001193125-23-246376
Sep 25, 2023EFFECT9999999995-23-002741
Sep 25, 2023EFFECT9999999995-23-002734
Sep 21, 2023S-3/A0001193125-23-239654
Sep 21, 2023S-1/A0001193125-23-239722
Sep 7, 2023DEFA14A0001193125-23-230645
Sep 7, 2023DEF 14A0001193125-23-230756
Sep 7, 20238-K/A0001193125-23-230634
Sep 5, 2023DEFA14A0001193125-23-228546
Sep 5, 2023S-10001193125-23-228641
Sep 5, 20238-K0001193125-23-228529